Can health information and decision aids decrease inequity in health care? A systematic review on the equality of their effectiveness
preprint
OA: closed
Abstract
Objectives Systematic review of studies evaluating evidence-based health information (EBHI) and decision aids (DAs) in terms of the extent to which inequity-producing factors have been considered and how these factors affect access to health-related information and informed decision-making. Study design Systematic review of randomised controlled trials. Methods Systematic searches were performed in the Cochrane Library, PubMed, Embase, PsycINFO, CINAHL, ERIC and PSYNDEX from inception to May 2023 to identify evaluation studies of EBHI and DAs that take into account factors associated with unequal opportunities as defined by PROGRESS Plus. Information on the effect of these factors was extracted and analysed in terms of outcomes relevant to the decision-making process. Results Few studies have examined the impact of EBHI/DAs on outcomes relevant to decision-making with respect to inequity-producing factors. In our final synthesis,12 studies were included. A positive association between the effectiveness of the intervention and the disadvantage status could be found twice and a negative association in three studies. Overall, most of the studies found no difference in knowledge gain, decision conflict and shared decision-making (SDM) between those advantaged and disadvantaged in terms of ethnicity, gender, education, age, income, health literacy, numeracy or socioeconomic status (SES). However, few trials examined this effect and the effect was considered solely in subgroup analyses that were probably underpowered, so asymmetries between these groups may not have been detected in the existing designs. Conclusion EBHI and DAs have been shown to be effective in promoting decision-making and thus in improving health care. To improve health care equitably, greater attention needs to be paid to methodological requirements in evaluations to fully capture potential differences in access to health-related information between individuals or in populations within the target groups of EBHI/DAs. PROSPERO registration CRD42018103456 What is already known? There is evidence that EBHI and DAs do not reach certain patient groups because while being developed and evaluated they do not adequately take into account differences in access to health-related information between different social groups. There is insufficient evidence whether EBHI and DAs are equally effective for people with factors that are more or less associated with equal access to health information. What the study adds A systematic review of evaluation studies of EBHI and DAs to consider factors that lead to inequity and analysis of how these factors influence the intervention effects in terms of access to health-related information and outcomes relevant for decision-making. How this study might affect research, practice or policy? Our research makes a valuable contribution to more equitable health care by stressing critical inequality factors that may influence informed decision-making with the help of EBHI and DAs.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
References (34)
- doi:10.1046/j.1369-6513.2001.00140.x via crossref
- doi:10.1002/14651858.cd001431.pub6 via crossref
- doi:10.1177/0272989x211014163 via crossref
- doi:10.1136/bmj.38926.629329.ae via crossref
- doi:10.1371/journal.pone.0094670 via crossref
- doi:10.1177/0272989x17706363 via crossref
- doi:10.1002/cncr.33248 via crossref
- doi:10.1016/j.jclinepi.2013.08.005 via crossref
- doi:10.1080/14639230701780408 via crossref
- doi:10.1016/j.pec.2020.04.010 via crossref
- doi:10.1177/0272989x211011101 via crossref
- doi:10.1136/bmj.n71 via crossref
- doi:10.1371/journal.pmed.1001333 via crossref
- doi:10.1186/s13643-016-0345-y via crossref
- doi:10.1136/bmj.l4898 via crossref
- doi:10.1136/bmj.39489.470347.ad via crossref
- doi:10.1186/1471-2288-8-8 via crossref
- doi:10.1111/j.1399-0004.2004.00405.x via crossref
- doi:10.1111/ajt.14693 via crossref
- doi:10.1371/journal.pmed.1002800 via crossref
- doi:10.1016/j.ahj.2013.03.031 via crossref
- doi:10.1258/jms.2008.007110 via crossref
- doi:10.1016/j.pec.2012.12.013 via crossref
- doi:10.1097/tp.0000000000001273 via crossref
- doi:10.1080/09540129947587 via crossref
- doi:10.1002/1097-0223(200102)21:2<146::aid-pd3>3.0.co;2-m via crossref
- doi:10.1111/hex.12965 via crossref
- doi:10.1080/09581596.2021.1951668 via crossref
- doi:10.1186/s12911-016-0303-6 via crossref
- doi:10.1177/0272989x211020317 via crossref
- doi:10.1186/1472-6947-13-s2-s10 via crossref
- doi:10.1186/s12911-016-0281-8 via crossref
- doi:10.1007/s11606-016-3609-2 via crossref
- doi:10.1002/14651858.cd013303.pub2 via crossref
Source provenance
- crossref
- last seen: 2026-05-20T01:00:22.082317+00:00
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00